Last updated: February 26, 2008
Sponsor: Aalborg University Hospital
Overall Status: Completed
Phase
3
Condition
Venous Thrombosis
Claudication
Vascular Diseases
Treatment
N/AClinical Study ID
NCT00628576
VN 2003/15 (2-16-4 - 0001- 03)
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
First DVT with or without known risk factors except overt cancer
Second DVT more than two years after the first if the patient was without clinicalsigns of CVI.
Exclusion
Exclusion Criteria:
Contraindication to anticoagulation therapy
Candidate to thrombectomy with arterious-venous fistula or thrombolytic therapy
Known cancer at the time of the DVT diagnosis
Patients unable to cooperate for anticoagulation therapy or manage the tests.
Study Design
Total Participants: 99
Study Start date:
October 01, 1993
Estimated Completion Date:
June 30, 2004
Study Description
Connect with a study center
Dept. of Haematology; Aalborg Hospital
Aalborg, Region Nordjylland 9000
DenmarkSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.